Supplementary Figure S5 from OvaPrint—A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer
Year: 2023
Type: supplementary-materials
Abstract: Figure S5: OvaPrint™ analysis of stage IV HGSOC plasma samples
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4389792751
